Aeglea was founded in 2013 to re-imagine the potential of human enzyme therapeutics. Our relentless mission is to deliver disruptive solutions that can provide meaningful benefit for many patients with rare genetic diseases. Every day, we strive to…
- Look beyond the conventional, redefining the potential of human enzymes to deliver disruptive solutions
- Work with purpose, driven by the urgent needs of the communities we serve
- Pursue our vision to become the premier human enzyme company
- Ultimately, change the lives of patients and their families now and for the future.